Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Age | 1 |
| Alzheimers Disease | 1 |
| Biochemistry | 1 |
| Brain | 1 |
| Control Groups | 1 |
| Genetics | 1 |
| Measures (Individuals) | 1 |
| Neurological Impairments | 1 |
| Patients | 1 |
| Risk | 1 |
| Scores | 1 |
| More ▼ | |
Source
| Brain | 1 |
Author
| Blennow, Kaj | 1 |
| Burger, Katharina | 1 |
| Ewers, Michael | 1 |
| Hampel, Harald | 1 |
| Shen, Yong | 1 |
| Teipel, Stefan J. | 1 |
| Wallin, Anders | 1 |
| Zhong, Zhenyu | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkEwers, Michael; Zhong, Zhenyu; Burger, Katharina; Wallin, Anders; Blennow, Kaj; Teipel, Stefan J.; Shen, Yong; Hampel, Harald – Brain, 2008
The Apolipoprotein (ApoE) [epsilon]4 allele is a major genetic risk factor of Alzheimer's disease, and may affect the production of amyloid beta (A[beta][subscript 1-42]). Recently, we have shown that [beta]-secretase (BACE 1) activity can be reliably detected within the brain and human CSF. Here, we have examined an association between the ApoE…
Descriptors: Alzheimers Disease, Risk, Patients, Neurological Impairments
